Unity Biotechnology's total assets for Q4 2024 were $37.66M, a decrease of -20.09% from the previous quarter. UBX total liabilities were $31.17M for the fiscal quarter, a -5.52% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.